Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1998 Apr;227(4):485–491. doi: 10.1097/00000658-199804000-00006

Effects of glutamine supplements and radiochemotherapy on systemic immune and gut barrier function in patients with advanced esophageal cancer.

S Yoshida 1, M Matsui 1, Y Shirouzu 1, H Fujita 1, H Yamana 1, K Shirouzu 1
PMCID: PMC1191301  PMID: 9563534

Abstract

OBJECTIVE: The objective of this study was to determine whether oral glutamine supplements can protect lymphocyte and gut barrier function in patients with advanced esophageal cancer undergoing radiochemotherapy. SUMMARY BACKGROUND DATA: Glutamine supplements improved protein metabolism in tumor bearing rats who underwent chemotherapy and reduced the toxicity of chemotherapy through an enhancement of glutathione production in rats. METHODS: Thirteen patients with esophageal cancer were randomly placed in either a control or a glutamine group. Glutamine was administered orally (30 g/day) at the start of radiochemotherapy and for the subsequent 28 days. All patients underwent mediastinal irradiation and chemotherapy consisting of 5-fluorouracil and cisplatin. The lymphocyte count was determined, and blast formation was assessed after stimulation with phytohemagglutinin and concanavalin A. Gut barrier function was assessed by measuring the total amount of phenolsulfonphthalein excreted in the urine after the oral administration of phenolsulfonphthalein. RESULTS: Glutamine supplements prevented a reduction in the lymphocyte count (control: 567 +/- 96/mm3 vs. glutamine: 1007 +/- 151, p < 0.05), and blast formation of lymphocyte (phytohemagglutinin, control: 19478 +/- 2121 dpm vs. glutamine: 33860 +/- 1433, p < 0.01, concanavalin A, control: 19177 +/- 1897 dpm vs. glutamine: 29473 +/- 2302, p < 0.01), and amount of phenolsulfonphthalein excretion in the urine was greater with control than with glutamine group (control: 15.4 +/- 2.4% vs. glutamine: 7.4 +/- 1.2, p < 0.05) 7 days after the initiation of radiochemotherapy. CONCLUSIONS: Oral glutamine supplementation protects lymphocytes and attenuates gut permeability in patients with esophageal cancer during radiochemotherapy.

Full text

PDF
485

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alverdy J. A., Aoys E., Weiss-Carrington P., Burke D. A. The effect of glutamine-enriched TPN on gut immune cellularity. J Surg Res. 1992 Jan;52(1):34–38. doi: 10.1016/0022-4804(92)90275-5. [DOI] [PubMed] [Google Scholar]
  2. Ardawi M. S. Glutamine and glucose metabolism in human peripheral lymphocytes. Metabolism. 1988 Jan;37(1):99–103. doi: 10.1016/0026-0495(88)90036-4. [DOI] [PubMed] [Google Scholar]
  3. Austgen T. R., Dudrick P. S., Sitren H., Bland K. I., Copeland E., Souba W. W. The effects of glutamine-enriched total parenteral nutrition on tumor growth and host tissues. Ann Surg. 1992 Feb;215(2):107–113. doi: 10.1097/00000658-199202000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Coia L. R., Engstrom P. F., Paul A. Nonsurgical management of esophageal cancer: report of a study of combined radiotherapy and chemotherapy. J Clin Oncol. 1987 Nov;5(11):1783–1790. doi: 10.1200/JCO.1987.5.11.1783. [DOI] [PubMed] [Google Scholar]
  5. Fox A. D., Kripke S. A., De Paula J., Berman J. M., Settle R. G., Rombeau J. L. Effect of a glutamine-supplemented enteral diet on methotrexate-induced enterocolitis. JPEN J Parenter Enteral Nutr. 1988 Jul-Aug;12(4):325–331. doi: 10.1177/0148607188012004325. [DOI] [PubMed] [Google Scholar]
  6. Fujita H., Kakegawa T., Yamana H., Shima I., Toh Y., Tomita Y., Fujii T., Yamasaki K., Higaki K., Noake T. Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy. Ann Surg. 1995 Nov;222(5):654–662. doi: 10.1097/00000658-199511000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hadfield T. L., Marcus S., Smart C. R. The effect of anticancer therapy on peripheral blood T and B lymphocyte counts and function. J Surg Oncol. 1979;11(3):217–225. doi: 10.1002/jso.2930110306. [DOI] [PubMed] [Google Scholar]
  8. Ishida K., Iizuka T., Ando N., Ide H. Phase II study of chemoradiotherapy for advanced squamous cell carcinoma of the thoracic esophagus: nine Japanese institutions trial. Jpn J Clin Oncol. 1996 Oct;26(5):310–315. doi: 10.1093/oxfordjournals.jjco.a023238. [DOI] [PubMed] [Google Scholar]
  9. Jenkins V. K., Olson M. H., Ellis H. N. In vitro methods of assessing lymphocyte transformation in patients undergoing radiotherapy for bronchogenic cancer. Tex Rep Biol Med. 1973 Spring;31(1):19–28. [PubMed] [Google Scholar]
  10. John M., Flam M., Wittlinger P., Mowry P. A. Inoperable esophageal carcinoma: results of aggressive synchronous radiotherapy and chemotherapy. A pilot study. Am J Clin Oncol. 1987 Aug;10(4):310–316. [PubMed] [Google Scholar]
  11. Kaibara A., Yoshida S., Yamasaki K., Ishibashi N., Kakegawa T. Effect of glutamine and chemotherapy on protein metabolism in tumor-bearing rats. J Surg Res. 1994 Jul;57(1):143–149. doi: 10.1006/jsre.1994.1122. [DOI] [PubMed] [Google Scholar]
  12. Keane T. J., Harwood A. R., Elhakim T., Rider W. D., Cummings B. J., Ginsberg R. J., Cooper J. C. Radical radiation therapy with 5-fluorouracil infusion and mitomycin C for oesophageal squamous carcinoma. Radiother Oncol. 1985 Nov;4(3):205–210. doi: 10.1016/s0167-8140(85)80085-2. [DOI] [PubMed] [Google Scholar]
  13. Klimberg V. S., Salloum R. M., Kasper M., Plumley D. A., Dolson D. J., Hautamaki R. D., Mendenhall W. R., Bova F. C., Bland K. I., Copeland E. M., 3rd Oral glutamine accelerates healing of the small intestine and improves outcome after whole abdominal radiation. Arch Surg. 1990 Aug;125(8):1040–1045. doi: 10.1001/archsurg.1990.01410200104017. [DOI] [PubMed] [Google Scholar]
  14. Kovacević Z., Morris H. P. The role of glutamine in the oxidative metabolism of malignant cells. Cancer Res. 1972 Feb;32(2):326–333. [PubMed] [Google Scholar]
  15. Lacey J. M., Wilmore D. W. Is glutamine a conditionally essential amino acid? Nutr Rev. 1990 Aug;48(8):297–309. doi: 10.1111/j.1753-4887.1990.tb02967.x. [DOI] [PubMed] [Google Scholar]
  16. MacLennan P. A., Brown R. A., Rennie M. J. A positive relationship between protein synthetic rate and intracellular glutamine concentration in perfused rat skeletal muscle. FEBS Lett. 1987 May 4;215(1):187–191. doi: 10.1016/0014-5793(87)80139-4. [DOI] [PubMed] [Google Scholar]
  17. McGhee J. R., Mestecky J., Elson C. O., Kiyono H. Regulation of IgA synthesis and immune response by T cells and interleukins. J Clin Immunol. 1989 May;9(3):175–199. doi: 10.1007/BF00916814. [DOI] [PubMed] [Google Scholar]
  18. Nakamura J., Takada S., Ohtsuka N., Heya T., Yamamoto A., Kimura T., Sezaki H. An assessment of indomethacin-induced gastrointestinal mucosal damage in-vivo: enhancement of urinary recovery after oral administration of phenolsulfonphthalein in rats. J Pharm Pharmacol. 1983 Jun;35(6):369–372. doi: 10.1111/j.2042-7158.1983.tb02958.x. [DOI] [PubMed] [Google Scholar]
  19. Newsholme P., Gordon S., Newsholme E. A. Rates of utilization and fates of glucose, glutamine, pyruvate, fatty acids and ketone bodies by mouse macrophages. Biochem J. 1987 Mar 15;242(3):631–636. doi: 10.1042/bj2420631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Prasad N., Prasad R., Thornby J., Harrell J. E., Hudgins P. T. Lymphocyte replication in lung cancer patients undergoing radiotherapy. Oncology. 1980;37(2):107–110. doi: 10.1159/000225415. [DOI] [PubMed] [Google Scholar]
  21. Ross D. Glutathione, free radicals and chemotherapeutic agents. Mechanisms of free-radical induced toxicity and glutathione-dependent protection. Pharmacol Ther. 1988;37(2):231–249. doi: 10.1016/0163-7258(88)90027-7. [DOI] [PubMed] [Google Scholar]
  22. Rouse K., Nwokedi E., Woodliff J. E., Epstein J., Klimberg V. S. Glutamine enhances selectivity of chemotherapy through changes in glutathione metabolism. Ann Surg. 1995 Apr;221(4):420–426. doi: 10.1097/00000658-199504000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Smith R. J., Wilmore D. W. Glutamine nutrition and requirements. JPEN J Parenter Enteral Nutr. 1990 Jul-Aug;14(4 Suppl):94S–99S. doi: 10.1177/014860719001400412. [DOI] [PubMed] [Google Scholar]
  24. Stratton J. A., Byfield P. E., Byfield J. E., Small R. C., Benfield J., Pilch Y. A comparison of the acute effects of radiation therapy, including or excluding the thymus, on the lymphocyte subpopulations of cancer patients. J Clin Invest. 1975 Jul;56(1):88–97. doi: 10.1172/JCI108084. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Tremel H., Kienle B., Weilemann L. S., Stehle P., Fürst P. Glutamine dipeptide-supplemented parenteral nutrition maintains intestinal function in the critically ill. Gastroenterology. 1994 Dec;107(6):1595–1601. doi: 10.1016/0016-5085(94)90797-8. [DOI] [PubMed] [Google Scholar]
  26. Welbourne T. C. Ammonia production and glutamine incorporation into glutathione in the functioning rat kidney. Can J Biochem. 1979 Mar;57(3):233–237. doi: 10.1139/o79-029. [DOI] [PubMed] [Google Scholar]
  27. Windmueller H. G. Glutamine utilization by the small intestine. Adv Enzymol Relat Areas Mol Biol. 1982;53:201–237. doi: 10.1002/9780470122983.ch6. [DOI] [PubMed] [Google Scholar]
  28. Windmueller H. G., Spaeth A. E. Uptake and metabolism of plasma glutamine by the small intestine. J Biol Chem. 1974 Aug 25;249(16):5070–5079. [PubMed] [Google Scholar]
  29. Yoshida S., Ishibashi N., Noake T., Shirouzu Y., Oka T., Shirouzu K. Glutamine and arginine metabolism in tumor-bearing rats receiving total parenteral nutrition. Metabolism. 1997 Apr;46(4):370–373. doi: 10.1016/s0026-0495(97)90049-4. [DOI] [PubMed] [Google Scholar]
  30. Yoshida S., Kaibara A., Yamasaki K., Ishibashi N., Noake T., Kakegawa T. Effect of glutamine supplementation on protein metabolism and glutathione in tumor-bearing rats. JPEN J Parenter Enteral Nutr. 1995 Nov-Dec;19(6):492–497. doi: 10.1177/0148607195019006492. [DOI] [PubMed] [Google Scholar]
  31. Yoshida S., Leskiw M. J., Schluter M. D., Bush K. T., Nagele R. G., Lanza-Jacoby S., Stein T. P. Effect of total parenteral nutrition, systemic sepsis, and glutamine on gut mucosa in rats. Am J Physiol. 1992 Aug;263(2 Pt 1):E368–E373. doi: 10.1152/ajpendo.1992.263.2.E368. [DOI] [PubMed] [Google Scholar]
  32. Yoshida S., Yamasaki K., Kaibara A., Mizote H., Kakegawa T. [Glutamine (Gln) supplementation in septic rats]. Nihon Geka Gakkai Zasshi. 1993 Oct;94(10):1078–1084. [PubMed] [Google Scholar]
  33. Ziegler T. R., Young L. S., Benfell K., Scheltinga M., Hortos K., Bye R., Morrow F. D., Jacobs D. O., Smith R. J., Antin J. H. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med. 1992 May 15;116(10):821–828. doi: 10.7326/0003-4819-116-10-821. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES